Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Changes in the Properties of the Preferred Retinal Locus with Eccentric Viewing Training.

Hassan SE, Ross NC, Massof RW, Stelmack J.

Optom Vis Sci. 2018 Dec 26. doi: 10.1097/OPX.0000000000001324. [Epub ahead of print]

PMID:
30589759
2.

Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias.

Kennedy NM, Schmid CL, Ross NC, Lovell KM, Yue Z, Chen YT, Cameron MD, Bohn LM, Bannister TD.

J Med Chem. 2018 Oct 11;61(19):8895-8907. doi: 10.1021/acs.jmedchem.8b01136. Epub 2018 Sep 24.

PMID:
30199635
3.

Feasibility of Telerehabilitation for Low Vision: Satisfaction Ratings by Providers and Patients.

Bittner AK, Yoshinaga P, Bowers A, Shepherd JD, Succar T, Ross NC.

Optom Vis Sci. 2018 Sep;95(9):865-872. doi: 10.1097/OPX.0000000000001260.

PMID:
30169361
4.

Utilization and Abandonment of Low Vision Devices Prescribed on a Mobile Clinic.

Gobeille MR, Malkin AG, Jamara R, Ross NC.

Optom Vis Sci. 2018 Sep;95(9):859-864. doi: 10.1097/OPX.0000000000001267.

PMID:
30169360
5.

Low Vision Enhancement with Head-mounted Video Display Systems: Are We There Yet?

Deemer AD, Bradley CK, Ross NC, Natale DM, Itthipanichpong R, Werblin FS, Massof RW.

Optom Vis Sci. 2018 Sep;95(9):694-703. doi: 10.1097/OPX.0000000000001278.

PMID:
30153240
6.

Clinical outcomes of low vision rehabilitation delivered by a mobile clinic.

Gobeille M, Malkin A, Jamara R, Ross NC.

Ophthalmic Physiol Opt. 2018 Mar;38(2):193-202. doi: 10.1111/opo.12440.

PMID:
29485207
7.

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics.

Schmid CL, Kennedy NM, Ross NC, Lovell KM, Yue Z, Morgenweck J, Cameron MD, Bannister TD, Bohn LM.

Cell. 2017 Nov 16;171(5):1165-1175.e13. doi: 10.1016/j.cell.2017.10.035.

8.

Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.

Aldrich JV, Senadheera SN, Ross NC, Reilley KA, Ganno ML, Eans SE, Murray TF, McLaughlin JP.

Br J Pharmacol. 2014 Jul;171(13):3212-22. doi: 10.1111/bph.12664.

9.

Considering Apical Scotomas, Confusion, and Diplopia When Prescribing Prisms for Homonymous Hemianopia.

Apfelbaum HL, Ross NC, Bowers AR, Peli E.

Transl Vis Sci Technol. 2013 May;2(4):2. Epub 2013 May 29.

10.

Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.

Patkar KA, Wu J, Ganno ML, Singh HD, Ross NC, Rasakham K, Toll L, McLaughlin JP.

J Pharmacol Exp Ther. 2013 Sep;346(3):545-54. doi: 10.1124/jpet.113.206086. Epub 2013 Jul 12.

11.

The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.

Aldrich JV, Senadheera SN, Ross NC, Ganno ML, Eans SO, McLaughlin JP.

J Nat Prod. 2013 Mar 22;76(3):433-8. doi: 10.1021/np300697k. Epub 2013 Jan 17.

12.

Peripheral prism glasses: effects of dominance, suppression, and background.

Ross NC, Bowers AR, Peli E.

Optom Vis Sci. 2012 Sep;89(9):1343-52. doi: 10.1097/OPX.0b013e3182678d99.

13.

Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.

Aldrich JV, Kulkarni SS, Senadheera SN, Ross NC, Reilley KJ, Eans SO, Ganno ML, Murray TF, McLaughlin JP.

ChemMedChem. 2011 Sep 5;6(9):1739-45. doi: 10.1002/cmdc.201100113. Epub 2011 Jul 14.

14.

Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.

Ross NC, Reilley KJ, Murray TF, Aldrich JV, McLaughlin JP.

Br J Pharmacol. 2012 Feb;165(4b):1097-108. doi: 10.1111/j.1476-5381.2011.01544.x.

15.

Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist.

Ross NC, Kulkarni SS, McLaughlin JP, Aldrich JV.

Tetrahedron Lett. 2010 Sep 20;51(38):5020-5023.

16.

Synthesis of cyclic tetrapeptide CJ 15,208: a novel kappa opioid receptor antagonist.

Kulkarni SS, Ross NC, McLaughlin JP, Aldrich JV.

Adv Exp Med Biol. 2009;611:269-70. No abstract available.

PMID:
19400188
17.

Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells.

Fink BD, O'Malley Y, Dake BL, Ross NC, Prisinzano TE, Sivitz WI.

PLoS One. 2009;4(1):e4250. doi: 10.1371/journal.pone.0004250. Epub 2009 Jan 22.

18.

Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria.

O'Malley Y, Fink BD, Ross NC, Prisinzano TE, Sivitz WI.

J Biol Chem. 2006 Dec 29;281(52):39766-75. Epub 2006 Oct 23.

Supplemental Content

Loading ...
Support Center